Literature DB >> 6187996

Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology.

M Osborn, K Weber.   

Abstract

In most cell types intermediate or 10-mm filaments (IF) are a major cytoskeletal organization and, thus, directly or indirectly influence the structural appearance of the cytoplasm. In line with the cell type-specific expression patterns of different IF proteins in normal animal and human tissue, IF typing distinguishes the major tumor groups, as documented by results with several hundred human tumors classified by conventional histologic methods. Carcinomas are characterized by cytokeratins, sarcomas of muscle cells by desmin, nonmuscle sarcomas by vimentin, and gliomas by glial fibrillary acidic protein. Furthermore, certain tumors originating from the sympathetic nervous system, e.g., ganglioneuroblastoma, pheochromocytoma, and at least some neuroblastomas, are characterized by the presence of neurofilaments. Carcinomas can often be further subdivided with regard to their possible derivation by examining their cytokeratin profiles. The IF type characteristic of the cell of origin seems to be kept not only in the primary tumor but usually also in solid metastases. In general, tumors do not acquire additional IF types. Therefore, IF typing can provide an unambiguous and rapid characterization in certain cases, that are difficult to diagnose by conventional techniques. Some useful examples are the small cell tumors of childhood and the discrimination between undifferentiated carcinoma and lymphoma. IF typing of a few tumors has already led to a revision or reconsideration of the original light microscopic diagnosis. The combined results indicate that at least certain carcinomas, as well as certain other tumor types, seem to arise by the selective multiplication of a particular and identifiable cell type present in the normal tissue. The procedure is not restricted to tumor material. IF typing of Mallory bodies, Alzheimer's disease tangles, certain myopathies, and the cells of the amniotic fluid offers further interesting applications. Thus, IF typing should become a valuable new tool both in histology and surgical pathology.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187996

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  198 in total

1.  Co-expression of vimentin and cytokeratins in M cells of rabbit intestinal lymphoid follicle-associated epithelium.

Authors:  M A Jepson; C M Mason; M K Bennett; N L Simmons; B H Hirst
Journal:  Histochem J       Date:  1992-01

2.  Cytokeratin expression in oral exfoliative cytology: effect of temperature and fixation.

Authors:  G R Ogden; S McQueen; E B Lane; M W Green; D Hopwood; D M Chisholm
Journal:  Histochem J       Date:  1992-03

3.  Changes in cytokeratin expression accompany squamous metaplasia of the human respiratory epithelium.

Authors:  P Stosiek; M Kasper; R Moll
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

4.  Phenotypic and ultrastructural characterization of an epithelial cell line established from rat thymic cultures.

Authors:  M Colić; S Gasić; N Stojanović; L Popović; A Dujić
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

5.  Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions. An immunocytochemical study.

Authors:  C Doglioni; P Dell'Orto; G Zanetti; P Iuzzolino; G Coggi; G Viale
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 6.  Notes on the application of microwaves in histopathology.

Authors:  A J Suurmeijer; M E Boon; L P Kok
Journal:  Histochem J       Date:  1990 Jun-Jul

7.  Differential immunohistochemical detection of cytokeratins and vimentin in the surgically removed human endolymphatic duct and sac.

Authors:  L J Bauwens; J C De Groot; F C Ramaekers; F Linthicum; J E Veldman; E H Huizing
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

8.  An investigation of cytokeratin expression in skin epithelial cysts and some uncommon types of cystic tumours using chain-specific antibodies.

Authors:  D Broekaert; L Goeman; F C Ramaekers; G N Van Muijen; H Eto; E B Lane; I M Leigh; J De Bersaques; P Coucke
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

9.  Vimentin expression in benign and malignant breast epithelium.

Authors:  M Heatley; C Whiteside; P Maxwell; P Toner
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

10.  Vimentin in oral squamous cell carcinoma.

Authors:  V C de Araujo; D S Pinto Júnior; S O de Sousa; F D Nunes; N S de Araujo
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.